|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent PAND insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why PAND insider buys are important for investors to follow.
Date | Insider | Price | Amount |
11-19-2020 Insider Buy |
Daniel J. Becker Director |
$15.12
CAGR »
|
$2,989,465.92 197,716 shares |
11-18-2020 Insider Buy |
Daniel J. Becker Director |
$15.29
CAGR »
|
$449,399.93 29,394 shares |
7-21-2020 Insider Buy |
Holding Ltd Roche >10% Owner |
$18.00
CAGR »
|
$649,998.00 36,111 shares |
7-21-2020 Insider Buy |
Mitchell Mutz Director and >10% Owner |
$18.00
CAGR »
|
$829,998.00 46,111 shares |
7-21-2020 Insider Buy |
Plc Glaxosmithkline Director and >10% Owner |
$18.00
CAGR »
|
$6,499,998.00 361,111 shares |
7-21-2020 Insider Buy |
RA CAPITAL MANAGEMENT, L.P. >10% Owner |
$18.00
CAGR »
|
$6,499,998.00 361,111 shares |
7-21-2020 Insider Buy |
Jill Carroll Director and >10% Owner |
$18.00
CAGR »
|
$6,499,998.00 361,111 shares |
7-21-2020 Insider Buy |
Boxer Capital, LLC >10% Owner |
$18.00
CAGR »
|
$12,999,996.00 722,222 shares |
7-21-2020 Insider Buy |
Partners GP Viii, L.L.C. Polaris >10% Owner |
$18.00
CAGR »
|
$649,998.00 36,111 shares |
7-21-2020 Insider Buy |
Eric D. Larson Vice President, Finance |
$18.00
CAGR »
|
$10,800.00 600 shares |
7-21-2020 Insider Buy |
Donald Frail Director |
$18.00
CAGR »
|
$180,000.00 10,000 shares |
7-21-2020 Insider Buy |
Joanne L. Viney See Remarks |
$18.00
CAGR »
|
$21,600.00 1,200 shares |
7-21-2020 Insider Buy |
Nancy Stagliano Director |
$18.00
CAGR »
|
$18,000.00 1,000 shares |
7-21-2020 Insider Buy |
John Sundy Chief Medical Officer |
$18.00
CAGR »
|
$36,000.00 2,000 shares |
7-21-2020 Insider Buy |
Rahul Kakkar Chief Executive Officer |
$18.00
CAGR »
|
$252,000.00 14,000 shares |
7-21-2020 Insider Buy |
Vikas Goyal See Remarks |
$18.00
CAGR »
|
$26,100.00 1,450 shares |
7-21-2020 Insider Buy |
Daniel J. Becker Director and >10% Owner |
$18.00
CAGR »
|
$13,017,996.00 723,222 shares |
7-21-2020 Insider Buy |
Christopher Fuglesang Director and >10% Owner |
$18.00
CAGR »
|
$12,999,996.00 722,222 shares |
7-21-2020 Insider Buy |
Alan L. Crane Director and >10% Owner |
$18.00
CAGR »
|
$901,998.00 50,111 shares |
Also See: Institutional Holders of PAND
Also See: SEC filings
Below we present the annualized performance delivered by PAND stock since 11-19-2020 (the date of the most recent
insider purchase). The performance of the investment from the time PAND insider buying occurred is the ultimate
test of whether insiders were right about PAND being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/20/2020 |
|
End date: |
04/01/2021 |
|
Start price/share: |
$17.11 |
|
End price/share: |
$60.05 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
250.96% |
|
Annualized Gain: |
699.25% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$35,096.00 |
|
Years: |
0.36 |
|
PAND Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent PAND insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding PAND
|
|